RGEN Relative Valuation
RGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RGEN is overvalued; if below, it's undervalued.
Historical Valuation
Repligen Corp (RGEN) is now in the Fair zone, suggesting that its current forward PE ratio of 85.94 is considered Fairly compared with the five-year average of 84.15. The fair price of Repligen Corp (RGEN) is between 123.26 to 184.73 according to relative valuation methord.
Relative Value
Fair Zone
123.26-184.73
Current Price：165.76
Fair
85.94
PE
1Y
3Y
5Y
Trailing
Forward
59.64
EV/EBITDA
Repligen Corp. (RGEN) has a current EV/EBITDA of 59.64. The 5-year average EV/EBITDA is 56.79. The thresholds are as follows: Strongly Undervalued below 27.85, Undervalued between 27.85 and 42.32, Fairly Valued between 71.26 and 42.32, Overvalued between 71.26 and 85.73, and Strongly Overvalued above 85.73. The current Forward EV/EBITDA of 59.64 falls within the Historic Trend Line -Fairly Valued range.
79.87
EV/EBIT
Repligen Corp. (RGEN) has a current EV/EBIT of 79.87. The 5-year average EV/EBIT is 71.53. The thresholds are as follows: Strongly Undervalued below 26.30, Undervalued between 26.30 and 48.92, Fairly Valued between 94.15 and 48.92, Overvalued between 94.15 and 116.77, and Strongly Overvalued above 116.77. The current Forward EV/EBIT of 79.87 falls within the Historic Trend Line -Fairly Valued range.
11.75
PS
Repligen Corp. (RGEN) has a current PS of 11.75. The 5-year average PS is 14.05. The thresholds are as follows: Strongly Undervalued below 7.28, Undervalued between 7.28 and 10.67, Fairly Valued between 17.43 and 10.67, Overvalued between 17.43 and 20.81, and Strongly Overvalued above 20.81. The current Forward PS of 11.75 falls within the Historic Trend Line -Fairly Valued range.
63.96
P/OCF
Repligen Corp. (RGEN) has a current P/OCF of 63.96. The 5-year average P/OCF is 61.37. The thresholds are as follows: Strongly Undervalued below 32.86, Undervalued between 32.86 and 47.11, Fairly Valued between 75.62 and 47.11, Overvalued between 75.62 and 89.88, and Strongly Overvalued above 89.88. The current Forward P/OCF of 63.96 falls within the Historic Trend Line -Fairly Valued range.
76.68
P/FCF
Repligen Corp. (RGEN) has a current P/FCF of 76.68. The 5-year average P/FCF is 100.21. The thresholds are as follows: Strongly Undervalued below 34.69, Undervalued between 34.69 and 67.45, Fairly Valued between 132.97 and 67.45, Overvalued between 132.97 and 165.73, and Strongly Overvalued above 165.73. The current Forward P/FCF of 76.68 falls within the Historic Trend Line -Fairly Valued range.
Repligen Corp (RGEN) has a current Price-to-Book (P/B) ratio of 4.48. Compared to its 3-year average P/B ratio of 4.35 , the current P/B ratio is approximately 2.99% higher. Relative to its 5-year average P/B ratio of 5.40, the current P/B ratio is about -17.13% higher. Repligen Corp (RGEN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 1.24%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 0.91% , the current FCF yield is about -100.00% lower.
4.48
P/B
Median3y
4.35
Median5y
5.40
1.17
FCF Yield
Median3y
1.24
Median5y
0.91
Competitors Valuation Multiple
The average P/S ratio for RGEN's competitors is , providing a benchmark for relative valuation. Repligen Corp Corp (RGEN) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 21.91%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of RGEN increased by 15.16% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 314.06 to 6.51K.
The secondary factor is the Revenue Growth, contributed 21.91%to the performance.
Overall, the performance of RGEN in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Repligen Corp (RGEN) currently overvalued or undervalued?
What is Repligen Corp (RGEN) fair value?
How does RGEN's valuation metrics compare to the industry average?
What is the current P/B ratio for Repligen Corp (RGEN) as of Dec 05 2025?
What is the current FCF Yield for Repligen Corp (RGEN) as of Dec 05 2025?
What is the current Forward P/E ratio for Repligen Corp (RGEN) as of Dec 05 2025?